(Q51372363)

4 April 2018

title

Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial (English)

1 reference

4 April 2018

0 references

1 reference

4 April 2018

Nick Freemantle

1 reference

4 April 2018

Luigi Tavazzi

object named as

Luigi Tavazzi

1 reference

4 April 2018

Erland Erdmann

1 reference

4 April 2018

Lukas Kappenberger

object named as

Lukas Kappenberger

1 reference

4 April 2018

Jean-Claude Daubert

object named as

Jean-Claude Daubert

1 reference

4 April 2018

author name string

Daniel Gras

1 reference

4 April 2018

publication date

2 May 2012

1 reference

4 April 2018

European Journal of Heart Failure

published in

1 reference

4 April 2018

volume

1 reference

4 April 2018

issue

1 reference

4 April 2018

page(s)

628-634

1 reference

4 April 2018

Cardiac resynchronization in chronic heart failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Baseline characteristics of patients recruited into the CARE-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Cardiac-resynchronization therapy for the prevention of heart-failure events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

European cardiac resynchronization therapy survey: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

The European cardiac resynchronization therapy survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

2010 Focused Update of ESC Guidelines on device therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS055

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFS055

1 reference

4 April 2018

1 reference

4 April 2018